Beta-interferon drug drawn into syringe from vial

Beta-interferon drug drawn into syringe from vial

G255/0090 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 29.3MB

Downloadable file size: 1.5MB

Price image Pricing

Please login to use the price calculator


This image is part of the feature Progress In Treating Multiple Sclerosis

Credit: JAMES KING-HOLMES/SCIENCE PHOTO LIBRARY

Caption: MODEL RELEASED. Beta-interferon drug. Woman uses a syringe to draw up liquid beta-interferon from a glass vial. This drug, new in 1995, is described as a "breakthrough" in the treatment of multiple sclerosis (MS). MS is caused by a deterioration of the myelin sheaths around nerve fibres leading to symptoms such as unsteady gait, speech and vision defects. It is a progressive disease caused when the body's own immune system attacks the myelin nerve sheaths. Daily injections of beta-interferon help to halve the number of attacks in people in the early stages of MS. This treatment, although expensive, offers hope and relief to MS sufferers while scientists try to find a cure for MS.

Release details: Model release available. Property release not required.

Keywords: beta, beta interferon, bioengineered, bioengineering, biotechnology, drug, drugs, female, filling, genetic, genetics, interferon, manufacture, ms, multiple sclerosis, needle, phial, production, protein, syringe, vertical, vial, viral inhibitor, woman

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.